Liu, C., Huang, W., Fu, C., Sun, H., Zhao, Q., Zhao, C., Chen, X., Li, B. (2025). Neoadjuvant SHR-1701 (a bifunctional anti-PD-L1/TGF-βRII agent) combined with chemoradiotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC): A phase II trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.410